<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02488356</url>
  </required_header>
  <id_info>
    <org_study_id>INQP1200</org_study_id>
    <nct_id>NCT02488356</nct_id>
  </id_info>
  <brief_title>Litramine for Weight Loss</brief_title>
  <official_title>Safety and Efficacy of Litramine IQP G-002AS for Weight Loss: A Randomised, Double-blind, Placebo-controlled, Parallel-group Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>InQpharm Group</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>InQpharm Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Safety and Efficacy of Litramine in weight loss.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in body weight from baseline</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">99</enrollment>
  <condition>Weight Loss</condition>
  <arm_group>
    <arm_group_label>Litramine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patented fibre complex from Opuntia ficus-indica (Litramine)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Inert fillers that is manufactured to look and taste the same as verum</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Litramine</intervention_name>
    <arm_group_label>Litramine</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>IQP G-002AS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy subjects ≥18 and ≤ 60 years of age

          -  Body mass index (BMI) ≥ 25 and ≤35 kg/m2

          -  Judged by the Investigator to be in general good health on the basis of medical
             history

          -  Judged by the Investigator to be motivated to lose weight

          -  Accustomed to 3 main meals per day

          -  Consistent and stable body weight 3 months prior to study enrollment (±5%)

          -  Consistent regular physical activity

          -  Agree to stop all medications and supplements during the entire length of the study

          -  Commitment to adhere to diet and lifestyle recommended for the study

          -  Females of child bearing potential must agree to use appropriate birth control methods
             during the entire study period

          -  Stable concomitant medications

          -  Understands the study procedures and signs forms providing informed consent to
             participate in the study and authorization for release of relevant protected health
             information to the study investigator

        Exclusion Criteria:

          -  Presence of any active gastrointestinal disease

               -  Malabsorption disorders

               -  Pancreatitis

               -  Stenosis in the GI tract

               -  Bariatric surgery/Lapband and bypass surgery

               -  Abdominal surgery within 6 months prior to the study

          -  Subjects whose weight increases 1.5 pounds from screening to the baseline visit

          -  History of eating disorders like bulimia, anorexia nervosa, binge-eating

          -  Renal conditions / disease, history of nephrolithiasis

          -  Cardiac diseases requiring drug therapy

          -  Other serious organ or systemic diseases such as diabetes mellitus, standard laundry
             list of cardiac diseases

          -  Osteoporosis or on medications for osteoporosis

          -  Known sensitivity to the ingredients of the study medication

          -  Vegetarian or Vegan

          -  Daily use of dietary supplement (2 week washout is allowed)

          -  Any medication that could influence gastrointestinal functions such as antibiotics,
             laxatives, opioids, anticholinergics, or anti-diarrheals (must have stopped at least 3
             months before study start)

          -  Subjects who are pregnant or lactating

          -  Any medication or use of products for the treatment of obesity (e.g., Xenical, other
             fat binder, fat burner, satiety products etc.)

          -  Subjects who are currently on carbohydrate and protein diet, or low fat diet

          -  More than 3 hours of strenuous physical activity per week

          -  History of abuse of drugs, alcohol or medication

          -  Smoking cessation within the 6 months prior to this study

          -  Subjects unable to understand or follow the study protocol

          -  Participation in similar study or weight loss program within 6 months prior to this
             study

          -  Participation in other studies with in the last 4 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2015</study_first_submitted>
  <study_first_submitted_qc>July 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2015</study_first_posted>
  <last_update_submitted>August 25, 2015</last_update_submitted>
  <last_update_submitted_qc>August 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

